#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Frontotemporal dementia Neovascular age-related macular degeneration Uveal melanoma Hairy cell leukaemia recurrent Immune-mediated myositis Anaplastic large cell lymphoma T- and null-cell types Waldenstrom's macroglobulinaemia refractory Blastic plasmacytoid dendritic cell neoplasia C3 glomerulopathy Medulloblastoma recurrent Stargardt's disease Factor VIII deficiency Narcolepsy Squamous cell carcinoma of the oral cavity Pyruvate kinase deficiency anaemia More trials…

    Learn about Rare Diseases

    Toxic epidermal necrolysis – Diagnostics Angiosarcoma recurrent Alexander disease – Treatment Phenylketonuria – Treatment Leiomyosarcoma – Trials in Disease Rhabdomyosarcoma – Life with Disease Bronchopulmonary dysplasia – Life with Disease Medulloblastoma – Trials in Disease Factor IX deficiency – Diagnostics Mucopolysaccharidosis III – Diagnostics More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Ubamatamab Omeprazole Palivizumab Levamisole Hydrochloride Namodenoson Potassium Oxybate Pariglasgene Brecaparvovec Amiloride XENON (133XE) Ovolecithin Pevonedistat Dalteparin Sodium Tamuzimod Acetate IHMA-2121908-1 Tyra-300-B01 Danicamtiv Glucose, Anhydrous Cilastatin Pilocarpine Hydrochloride Laronidase More therapies…

    Learn about Your Condition

    Hypophosphatasia Mixed-type liposarcoma Varicella Krabbe's disease Nicotine dependence Renal disorder Metastases to meninges Head injury HIV infection Hypochromic anaemia Neuropathy peripheral Sickle cell disease Pancreaticoduodenectomy Blood iron increased Oesophageal carcinoma More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

ABM

  • Study of Pembrolizumab and V940 for Treating Non-Small Cell Lung Cancer in Patients with Resectable Stage II to IIIB (N2) Not Achieving Complete Response

    Recruiting

    3 1 1
    Investigated Diseases:
    • Non-small cell lung cancer
    Investigated Drugs:
    • Pemetrexed Disodium
    • Carboplatin
    • Cisplatin
    Belgium Bulgaria Finland France Germany Greece +8

  • Comparison of Once Versus Twice Daily Prednisolone Administration on Blood Glucose Control in Patients with ANCA-Associated Vasculitis

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Anti-neutrophil cytoplasmic antibody positive vasculitis
    Investigated Drugs:
    • Prednisolone
    Austria

  • Study on the Safety and Benefits of Recombinant Human Plasma Gelsolin for Patients with Moderate-to-Severe Acute Respiratory Distress Syndrome (ARDS)

    Recruiting

    2 1
    Investigated Diseases:
    • Acute respiratory distress syndrome
    Investigated Drugs:
    • Human Plasma Gelsolin, Recombinant
    Belgium Bulgaria Czechia France Germany Hungary +4

  • Study of nivolumab treatment for patients with nasopharyngeal cancer who did not respond to or worsened after platinum chemotherapy

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Keratinising squamous cell carcinoma of nasopharynx
    • Nasopharyngeal cancer
    • Nasopharyngeal cancer recurrent
    Investigated Drugs:
    • Nivolumab
    Poland

  • Study on Steroid Withdrawal in Systemic Lupus Erythematosus Patients Using Prednisone

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Systemic lupus erythematosus
    Investigated Drugs:
    • Prednisone
    Italy

  • Study on Pressurized Intraperitoneal Aerosol Chemotherapy with Fluorouracil for Patients with Gastric Cancer with Peritoneal Metastases

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Adenocarcinoma gastric
    Investigated Drugs:
    • Calcium Levofolinate
    • Cisplatin
    • Docetaxel
    Italy
Previous Page
1 … 422 423 424 425 426 … 1,651
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!